Economic Evaluation and Cost-Effectiveness Thresholds: Signals to Firms and Implications for R&D Investment and Innovation

By Vernon John A.  

PharmacoEconomics, Vol. 27, Iss. 10, 2009-10 ,pp. : 797-806

Adis International

Access to resources Recommend Favorite

Economic and Cost-Effectiveness Considerations for Pharmacogenetics Tests: An Integral Part of Translational Research and Innovation Uptake in Personalized Medicine

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 7, Iss. 4, 2009-12 ,pp. : 284-296

Bentham Science Publishers

Access to resources Recommend Favorite

Cost–effectiveness analysis in pharmacogenomics

By Payne Katherine   Shabaruddin Fatiha H  

Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. : 643-646

Future Medicine

Access to resources Recommend Favorite

Cost effectiveness of ixabepilone debated

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 576, 2009-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

The cost of pharmaceutical innovation to patients

By Keyhani Salomeh   Ross Joseph S  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 11, 2007-11 ,pp. : 1431-1434

Informa Healthcare

Access to resources Recommend Favorite